Top compounds associated with response to MARK2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0062 0.9
mRNA LBW242 CCLE pan-cancer AAC -0.006 0.9
mRNA SU11274 CTRPv2 pan-cancer AAC 0.0042 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0045 0.9
mRNA PD318088 CTRPv2 pan-cancer AAC 0.0041 0.9
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.0059 0.9
mRNA FK866 CTRPv2 pan-cancer AAC 0.0043 0.9
mRNA AMG-706 FIMM pan-cancer AAC 0.019 0.9
mRNA Vorinostat FIMM pan-cancer AAC -0.017 0.9
mRNA AP-24534 FIMM pan-cancer AAC 0.019 0.9
Download CSV